Table 2 Univariate analysis results of factors affecting hyperuricemia

WBC

5.93 ± 1.25

5.83 ± 1.66

0.744

0.061

0.327

RBC

4.62 ± 0.69

4.55 ± 0.52

0.121

0.131

1.548

PCV

41.16 ± 5.21

42.41 ± 4.12

0.108

0.302

−1.608

NEUT%

63.29(53.93,72.65)

61.01(52.06,69.96)

< 0.05

0.254

2.974

ANC

4.36(2.63,6.09)

3.71(2.34,5.08)

< 0.05

0.47

5.568

WEIGHT

70.26(58.33,82.19)

60.79(49.27,72.31)

< 0.05

0.821

7.693

MONO%

5.75(3.68,7.82)

5.75(3.79,7.71)

0.962

0

−0.047

MONO#

0.38(0.22,0.54)

0.34(0.20,0.48)

< 0.05

0.284

3.354

BASO%

0.42 ± 0.19

0.38 ± 0.28

0.193

0.144

1.302

BASO#

0.03 ± 0.01

0.02 ± 0.02

< 0.05

0.506

2.302

EOS%

2.43 ± 1.81

2.32 ± 2.04

0.535

0.054

0.621

EOS#

0.16 ± 0.13

0.14 ± 0.13

< 0.05

0.154

1.991

MCV

93.19 ± 5.97

92.90 ± 5.65

0.558

0.051

0.585

MCHC

329.01(317.79,340.23)

332.25(323.83,340.67)

0.229

0.38

1.203

MCH

30.65 ± 2.27

30.46 ± 2.15

0.298

0.088

1.04

LYM

28.16(19.75,36.57)

30.57(22.14,39.00)

< 0.05

0.286

−3.35

LYM#

1.84(1.24,2.44)

1.80(1.14,2.46)

0.476

0.061

0.712

RDW-CV

28.24 ± 16.26

22.54 ± 14.89

< 0.05

0.381

4.131

RDW-SD

43.02 ± 8.71

41.23 ± 10.44

0.051

0.172

1.951

PDW

16.04 ± 0.92

15.98 ± 1.32

0.604

0.046

0.519

PCT

0.20 ± 0.06

0.20 ± 0.06

0.997

0

0.004

MPV

10.31 ± 1.35

10.27 ± 1.44

0.744

0.028

0.326

PLT

196.85(140.04,253.66)

198.98(137.87,260.09)

0.682

0.035

−0.409

HGB

140.88(122.20,159.56)

138.09(122.33,153.85)

< 0.05

0.176

2.053

AGE

63.96(49.44,78.48)

60.70(45.73,75.67)

< 0.05

0.218

2.585

SEX

1.31 ± 0.46

1.57 ± 0.50

< 0.05

0.525

−6.234